Final Programme

28
Satellite Symposia Sunday, 29 March 2009
13:30– Satellite Symposium Room F1
15:30
The way forward in haematological malignancies:
a forum for practitioners
Chairs: P. Fenaux (Bobigny, FR); E. Hellström-Lindberg (Stockholm, SE)
13:30 Welcome and introduction
S48 The role of the stem cell transplant in myelodysplastic syndromes
13:35 G. Mufti (London, UK)
S49 Azacitidine: the first drug to prolong the survival of patients with
14:00 myelodysplastic syndromes
P. Fenaux (Bobigny, FR)
S50 Azacitidine in clinical practice
14:25 L. Silverman (New York, US)
S51 Lenalidomide in Low- and Int-1 myelodysplastic syndromes
14:45 A. Giagounidis (Duisburg, DE)
S52 Lenalidomide in non-Hodgkin lymphoma and chronic lymphocytic leukaemia
15:00 M. Czuczman (Buffalo, US)
15:25 Closing remarks
Satellite Symposium organised by Celgene International Sàrl
13:30–
15:30
Satellite Symposium
Fungal infections in patients with haematologic
malignancies: diagnose or prevent?
Chair: K. Marr (Seattle, US)
Room E3
S53 Programme overview / Opening comments
13:30 K. Marr (Seattle, US)
S54 From invasive fungal infection to invasive fungal disease:
13:35 theoretical rationale and clinical application
J. Maertens (Leuven, BE)
S55 An analysis of non-culture–based microbiological tools in today’s practice
13:55 K. Marr (Seattle, US)
S56 Therapeutic drug monitoring during antifungal prophylaxis: is it necessary?
14:20 O. Cornely (Cologne, DE)
S57 Antifungal prophylaxis in patients with HSCT/GvHD: what have we learned?
14:45 J. Maertens (Leuven, BE)
15:10 Panel discussion
15:25 Concluding remarks
Satellite Symposium organised by Schering-Plough